Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $527.1800 (-3.56%) ($525.2300 - $557.1900) on Fri. Aug. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.53% (three month average) | RSI | 44 | Latest Price | $527.1800(-3.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.7% a day on average for past five trading days. | Weekly Trend | REGN declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(66%) XLV(54%) XBI(51%) QQQ(43%) SPY(42%) | Factors Impacting REGN price | REGN will decline at least -6.265% in a week (0% probabilities). VIXM(-17%) TLT(-9%) UUP(-5%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.265% (StdDev 12.53%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $564.93 | 5 Day Moving Average | $557.83(-5.49%) | 10 Day Moving Average | $565.92(-6.85%) | 20 Day Moving Average | $564.93(-6.68%) | To recent high | -11% | To recent low | 7.1% | Market Cap | $55.896b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |